Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.13 USD | -4.12% | -3.20% | +32.95% |
May. 09 | Wedbush Raises Price Target on Revolution Medicines to $46 From $42, Maintains Outperform Rating | MT |
May. 08 | Revolution Medicines Q1 Net Loss Narrows | MT |
Financials (USD)
Sales 2024 * | 2.19M | Sales 2025 * | 2.67M | Capitalization | 6.56B |
---|---|---|---|---|---|
Net income 2024 * | -512M | Net income 2025 * | -588M | EV / Sales 2024 * | 2,373 x |
Net cash position 2024 * | 1.37B | Net cash position 2025 * | 846M | EV / Sales 2025 * | 2,143 x |
P/E ratio 2024 * |
-12.7
x | P/E ratio 2025 * |
-11.2
x | Employees | 411 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.08% |
Latest transcript on Revolution Medicines, Inc.
1 day | -4.12% | ||
1 week | -3.20% | ||
Current month | +2.28% | ||
1 month | +4.67% | ||
3 months | +31.26% | ||
6 months | +77.85% | ||
Current year | +32.95% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Goldsmith
CEO | Chief Executive Officer | 62 | 14-09-30 |
Jack Anders
DFI | Director of Finance/CFO | 47 | 18-07-31 |
Wally Reiher
CTO | Chief Tech/Sci/R&D Officer | - | 15-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Goldsmith
CEO | Chief Executive Officer | 62 | 14-09-30 |
Alexis Borisy
BRD | Director/Board Member | 52 | 14-10-31 |
Sandra Horning
BRD | Director/Board Member | 75 | Nov. 08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.16% | 0 M€ | 0.00% | - | |
0.12% | 0 M€ | 0.00% | - | |
0.05% | 1,487 M€ | +8.16% | - | |
0.05% | 746 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 38.13 | -4.12% | 1,795,706 |
24-05-22 | 39.77 | +0.28% | 995,504 |
24-05-21 | 39.66 | -0.92% | 1,327,779 |
24-05-20 | 40.03 | +1.57% | 2,254,997 |
24-05-17 | 39.41 | +1.08% | 1,118,299 |
Delayed Quote Nasdaq, May 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.95% | 6.56B | |
+64.92% | 62.59B | |
-1.85% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+13.05% | 26.21B | |
-21.96% | 19.09B | |
+4.21% | 13.08B | |
+25.74% | 12.26B | |
+27.42% | 12.05B |
- Stock Market
- Equities
- RVMD Stock